| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |